הלוואות ואשראי לטווח ארוך של החברה: ENDRA (NDRA)

ENDRA Life Sciences (NDRA) minimizes operational risks by creating an affordable alternative to MRI through thermoacoustic scanning. This methodology targets hepatologists and medical centers to combat mass liver obesity within the vast screening market. The company's debt stands at 0.00, and this price chart reflects the dynamics of an asset whose probe production has been efficiently outsourced to third-party contractors under strict quality control.

The complex logistics of transporting high-precision liver diagnostic electronics require significant capital expenditures in supply infrastructure. This metric aggregates all long-term credit obligations of ENDRA Life Sciences (NDRA), reflecting the scale of borrowed funds for periods exceeding one year. By analyzing the dynamics of the business's long-term debt capital, an investor assesses the sustainability of the financial leverage. An increase in this indicator suggests expansion but raises the debt load. The final debt-to-asset ratio determines the company's cost of capital.